Abstract | MicroRNAs (miRNAs) are small RNAs that post-transcriptionally regulate the expression of thousands of genes in a broad range of organisms in both normal physiological contexts and in disease contexts. miRNA expression profiling is gaining popularity because miRNAs, as key regulators in gene expression networks, can influence many biological processes and also show promise as biomarkers for disease. Technological advances have spawned a multitude of platforms for miRNA profiling, and an understanding of the strengths and pitfalls of different approaches can aid in their effective use. Here, we review the major considerations for carrying out and interpreting results of miRNA-profiling studies. 4, 5 . An emerging theme is that miRNA expression patterns can be cell-type-specific and that specific miRNAs can function to buffer developmental transitions and/or to maintain differentiation states, leading to interest in miRNA profiling for understanding stem cell biology and cellular reprogramming.
Since their discovery [1] [2] [3] , microRNAs (miRNAs) have come to be recognized as crucial regulators of gene expression in plants and animals. miRNAs are short (~22 nucleotides (nt) in length) non-coding RNAs (ncRNAs) that regulate gene expression by binding to specific mRNA targets and promoting their degradation and/or translational inhibition. In most organisms, there are a limited number of miRNAs compared with the number of mRNAs and proteins; for example, the human genome is believed to encode ~1,000 miRNAs, whereas the number of mRNAs is typically estimated at ~30,000. However, one miRNA may regulate hundreds of mRNAs and, as a result, may have substantial effects on gene expression networks. miRNA expression patterns can therefore be especially rich in biological information, as variation in expression of hundreds of mRNAs may, to an extent, be captured in the expression patterns of one or a few miRNAs that regulate them.
miRNA expression profiling has helped to identify miRNAs that regulate a range of processes, including organismal development and establishment and maintenance of tissue differentiation 4, 5 . Consequently, miRNAs are being investigated as reagents for the reprogramming of cell fate in stem cell applications, as well as being applied as biomarkers for identifying the tissue differentiation state of cancers of unknown tissue origin 6, 7 . Measuring miRNA expression can also be useful for systems-level studies of gene regulation, especially when miRNA measurements are combined with mRNA profiling and other genome-scale data. Finally, miRNAs have been shown to be unusually well-preserved in a range of specimen types -including blood plasma or serum, urine and formalin-fixed tissue blocks -and are also measurable with a much greater sensitivity than proteins. This has led to considerable interest in the development of miRNAs as biomarkers for diverse molecular diagnostic applications, including in cancer [6] [7] [8] , cardiovascular and autoimmune diseases 9 and forensics 10 . Applications of miRNA profiling are summarized in BOX 1. Accordingly, miRNA profiling has become of interest to investigators working in diverse research areas of biology and medicine. Here we define miRNA profiling as the measurement of the relative abundance of a cohort of miRNAs, ranging from a group of several miRNAs of specific biological interest to comprehensive profiling of all miRNAs in a given species (typically numbering in the several hundreds). Assaying such small RNA molecules poses some inherent challenges, but technological advances in recent years have overcome many of these barriers, and a wide range of approaches and platforms is now available for miRNA profiling.
In this article, we aim to explain fundamental details of miRNAs that are relevant to miRNA-profiling experiments, to describe established and emerging methods for measuring miRNA expression profiles in various biological samples (for example, cells, tissues and body fluids) and to highlight the strengths and limitations of different profiling approaches for specific biological applications. Our goal is to provide the reader with an informed perspective for embarking on miRNA-profiling studies or for interpreting miRNA-profiling results from the literature.
Tissue-based miRNA biomarkers. A common study design is to define differences in miRNA profiles between normal and affected tissues to look for biomarkers of disease, which may potentially be correlated with prognosis or therapeutic response. Each of the three main miRNA-profiling strategies has been used for biomarker discovery efforts in a wide variety of diseases, including cancer, autoimmune, psychiatric and neurological disorders [107] [108] [109] [110] [111] .
Tissues of unknown origin. miRNA profiles have been successfully applied to the classification of cancers of unknown origin difficult to classify otherwise 6, 7 . Clinical diagnostic assays have been developed based on miRNA-based classifiers that are generated from microarray studies of known tumour types 7, 112, 113 .
Circulating biomarkers. miRNAs, including specific cancer-derived miRNAs, are detectable in the cell-free circulation (that is, in serum and plasma) 34, 114 and thus circulating miRNAs have been eagerly sought as non-invasive biomarkers in many diseases and pathologic processes 8, 115 . Accompanying these efforts is the need for rigorous control of pre-analytic and analytic variables when considering potential circulating miRNA markers 35, 37, 116, 117 . Forensics. miRNA profiles from different body fluids have been characterized and have been proposed as distinguishers of different body fluids in the forensic setting 10, 118 .
MicroRNA characteristics
The considerations for planning and interpreting miRNA-profiling experiments are related to the characteristics of these small RNAs and their mode of biogenesis and function. The basic pathway of miRNA biogenesis is described in Supplementary information S1 (figure) and is well-summarized in recent reviews 11, 12 . There are a few key points to bear in mind. Although mature miRNAs are typically ~22 nt long, they originate from much longer primary transcripts that may be hundreds to thousands of nucleotides in length. Biogenesis of mature miRNAs occurs through a multi-step process that begins with the cleavage of the primary miRNA (pri-miRNA) to yield an approximately 70-100 nt hairpin precursor miRNA (pre-miRNA) and is followed by further cleavage to produce the mature miRNA, meaning that profiling platforms need to distinguish pri-and pre-miRNAs from mature miRNAs. The average copy number of an individual miRNA species has been roughly estimated at ~500 per cell, which may be higher than the average expression of mRNA species 13, 14 . However, different miRNA species in cells vary widely in concentration over a dynamic range of at least four orders of magnitude, and some cell-type-restricted miRNAs are present at >10,000 copies per cell 14 . To date, the total number of different mature miRNAs in humans is estimated at ~1,000, and numbers in other well-studied organisms, such as Drosophila melanogaster, Caenorhabditis elegans and Arabidopsis thaliana, range between ~200 and 300 (according to mirBase version 18.0, accessed 22 January 2012). miRBase 15, 16 has emerged as a definitive repository of miRNA sequences as well as an authoritative source of miRNA nomenclature that is valuable for miRNAprofiling studies (Supplementary information S2 (box) provides detail on miRNA nomenclature). Originally called the microRNA Registry 17 , the current version of miRBase has a total of 18,226 entries of hairpin precursor miRNAs expressing 21,643 mature miRNA products (miRBase version 18.0, accessed 22 January 2012) encompassing a range of plant and animal species. In addition to providing information about predicted precursor hairpin sequences and experimentally identified mature miRNA sequences, miRBase provides an interface to quantitative RNA-sequencing (RNA-seq) data that are deposited in the US National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) repository as well as links to miRNA target prediction databases.
It is important to consider that different mature miRNA species can be produced from a single pre-miRNA molecule (FIG. 1) . Distinct miRNAs are generated from the 3′ and 5′ arms of the pre-miRNA duplex 11 . In addition, miRNA-sequencing studies indicate that a given mature miRNA can sometimes comprise a distribution of sizes centred around 22 nt rather than a discrete single length. For example, RNAseq data deposited in miRBase for human miR-9 show that miRNA-sequencing reads are distributed between 15-23 nt (FIG. 1) , although most are 22 or 23 nt. In many cases, this variation in mature miRNA length is due to 3′ or 5′ end post-transcriptional modifications (including additions and/or deletion of nucleotides), which have been shown to affect miRNA stability or function in some cases [18] [19] [20] [21] [22] . 
Figure 1 | MicroRNA sequence heterogeneity. The sequence of a precursor microRNA (pre-miRNA) for human miR-9 is given at the top. The fold of this molecule into a hairpin is shown below. Listed below the sequence is the size distribution of human miR-9 sequences based on RNA-sequencing (RNA-seq) data from melanoma cell lines 119 deposited in miRBase, which are provided here as an example of sequence length heterogeneity. The frequency of each variant as a percentage of the total sequencing reads is given on the left. Mature miRNAs are generally ~22 nucleotides in length and may be produced from both the 5′ (-5p) and 3′ (-3p) arms of the hairpin pre-miRNA. The bar graph above the pre-miRNA sequence indicates the relative frequency of each nucleotide among the mature miRNA reads originating from the pre-miRNA sequence. The canonical miR-9-5p and miR-9-3p sequences are highlighted in red and orange, respectively, and are also shown in the hairpin precursor. For miRNA-profiling studies, it is important to recognize that, depending on the technology used, not all miRNA forms will be detected with equal efficiency.
Primary miRNA (pri-miRNA). The initial transcription product of microRNA (miRNA) genes. Pri-miRNAs are generally >100 nucleotides long (frequently a few kilobases long) and may contain one or more miRNA stem-loops that are processed by the miRNA biogenesis machinery.
Precursor miRNA (pre-miRNA). A hairpin precursor of microRNA (miRNA) that is formed by the cleavage of the primary miRNA transcript by the Drosha-DGCR8 protein complex. Precursor miRNAs are typically ~70-100 nucleotides long. 
Sample considerations
Sample processing and RNA extraction methods can have a substantial impact on the results of miRNA profiling, particularly for samples that are prone to miRNA degradation [23] [24] [25] [26] . In this section, we highlight specimen considerations (TABLE 1) and the major methodologies for miRNA isolation and quality-control issues as they relate to different sample types, such as tissues and body fluids (FIG. 2) . Although the study of plant miRNAs is a dynamic and highly productive area of ongoing research, we focus here on the profiling of miRNAs in animals.
Sample types and miRNA extraction. It is possible to extract high-quality miRNA from a wide range of cell and tissue sources, including cell lines, fresh tissues, formalin-fixed paraffin-embedded (FFPE) tissues, plasma, serum, urine and other body fluids 27, 28 (TABLE 1) .
The principles for isolating miRNA are, in general, the same as for isolation of total RNA, except that miRNA isolation protocols are often slightly modified to retain (and sometimes to enrich) the small RNA fraction 28 . Widely used commercially available products are generally based on chemical extraction using concentrated chaotropic salts, such as guanidinium thiocyanate (for example, Trizol and QIAzol reagents), followed by a solid-phase extraction procedure on silica columns. miRNAs may also be analysed using total RNA isolated by traditional chemical extraction with Trizol without column purification, which has been reported to perform comparably well to small RNA-enriched total RNA for microarray analysis 29 . Many profiling platforms can distinguish between miRNAs and the many other, more abundant RNA species that are present in total cellular RNA. However, if small RNA enrichment is required, low-molecular-weight RNA (for example, in the 18-24 nt range to capture miRNAs) can be recovered by size fractionating and gel purifying the desired size range fraction on a polyacrylamide gel 30 ; for more crude enrichment, column-based protocols also exist.
Tissues and cell lines generally yield high-quality miRNA that is suitable for profiling studies. This is true even for FFPE tissue, in which profiles of extracted miRNA have been shown to correlate well with those obtained from matched frozen reference samples 31 . Unlike mRNA, which is highly fragmented and generally less reliable in FFPE tissue compared with fresh tissue, miRNA is surprisingly stable and intact in FFPE, and this stability is reported to be largely independent of formalin fixation time and duration of tissue block storage 31, 32 . This stability offers a distinct advantage of miRNA over mRNA as a tissue analyte in the clinical setting, where FFPE may be the only sample type available. At least two groups have compared different commercially available miRNA FFPE kits and described quantitative and qualitative differences in miRNA-profiling results that could be attributed to the extraction method 31, 33 . 
Pre-analytic variables
Variables that occur before sample assay. For example, the time elapsed between when a blood sample is drawn from the patient and when it is processed by the laboratory is a pre-analytic variable.
Argonaute (AGO). These proteins are the central components of RNA-silencing mechanisms. They provide the platform for target-mRNA recognition by short guide RNA strands (for example, miRNAs) and, in the case of AGO2 (in humans), the catalytic activity for mRNA cleavage.
Seed region
The six or seven nucleotides between the nucleotides positions 2-7 or 2-8 of the microRNA (miRNA) 5′ end that determine, in large measure, miRNA target selection by virtue of sequence complementarity to the miRNA seed region.
For some specimen types, the preparation and miRNA extraction methods may need to be specially optimized based on an understanding of the sample type being investigated. For example, human blood plasma is a challenging specimen type owing to high levels of endogenous RNase activity 34 and other pre-analytic variables, such as centrifugation conditions, white blood cell counts and red blood cell haemolysis, that have an impact on miRNA measurements [35] [36] [37] . Further, miRNAs exist in at least two distinct physical states in blood plasma -within vesicles (for example, exosomes and/or microvesicles) or associated with Argonaute (AGO)2-containing protein complexes -suggesting, for example, that specimen-processing conditions that alter vesicle content will influence miRNA profiles 38 .
Quality and quantity assessment. Assessment of the quality and quantity of extracted RNA is important for reproducibility and accuracy in miRNA-profiling studies. Because many profiling methods can be performed using total RNA, specific assessment of the miRNA population is not always necessary, and it is routine to assess the yield and degree of overall RNA integrity using spectrophotometry and automated capillary electrophoresis instruments, such as the Bioanalyzer 2100 (from Agilent) and Experion (from Bio-Rad) 29 . A small RNA chip is available for the Bioanalyzer 2100 for estimating miRNA abundance, expressed as the proportion of RNA in the 15-40 nt window relative to total RNA abundance. However, the estimation of miRNA abundance by this method may only be accurate when overall RNA integrity is very high 39 .
In situations in which assessment of RNA extraction efficiency is important (for example, in acellular liquid specimens such as plasma or serum in which extraction efficiency can vary from sample to sample), a known amount of synthetic miRNAs that are not expressed in the biological sample can be 'spiked-in' at an early step in RNA isolation. For example, a mixture of three non-conserved C. elegans miRNAs has been used for plasma samples. These control miRNAs are then measured in the purified RNA to normalize for variation in RNA extraction efficiency and/or inhibitors of reverse transcription or PCR 40 .
MicroRNA-profiling methods
In this section, we review the general concepts and special challenges that are relevant to miRNA profiling. We discuss methodology, highlight strengths and limitations and cite examples of successful use. General concepts and special challenges in miRNA profiling. Many properties that are unique to miRNAs pose challenges to their accurate detection and quantification 41 . For instance, the ~22 nt length of mature miRNAs is insufficient for annealing to traditional primers that are designed for reverse transcription and PCR. In addition, unlike mRNAs, miRNAs lack a common sequence, such as a poly(A) tail, that can be used for selective enrichment or as a universal primer-binding site for reverse transcription. This is important because miRNAs represent a small fraction (~0.01%) of the total RNA mass and must therefore be selectively detected in a background of other, diverse RNA species, including priand pre-miRNA precursors that also contain the RNA sequence of the mature miRNA species. In addition, miRNAs within a family (for example, the let-7 family) can differ by as little as a single nucleotide, making the ability to discriminate between forms with singlenucleotide differences important. Finally, there can be sequence length variability in biological samples, even for a single miRNA (FIG. 1) . In many cases, this is due to variants (so-called 'isomiRs') 21, 22, 42 , which result from post-transcriptional nucleotide additions to 3′ ends of mature miRNAs; presumed exonucleolytic cleavage can also occur at the 3′ end, resulting in sequences that are shorter than the canonical miRNA. Nucleotide addition or deletion at the 5′ end 43 , although less frequent, can have substantial effects on miRNA function because these changes shift the sequence of the seed regionthe seed region is typically defined as nucleotides 2-8 of the miRNA and is the predominant determinant of mRNA target selection. Nucleotide additions at the 3′ end, although they do not affect the seed region, may still have functional effects on miRNA stability and mRNAtargeting efficacy 18, 19, 21, 44, 45 . It is worth keeping in mind that the degree of sequence length heterogeneity tends to vary among different miRNAs, and the large majority of miRNAs typically show only modest length heterogeneity; however, depending on the goals of an miRNAprofiling experiment, measurement of different forms may need to be considered.
Another challenge for profiling hundreds of miRNAs in parallel is that, owing to their short length, variance in miRNA GC content leads to a wide variance in melting temperatures (T m ) for annealing reactions, creating miRNA-specific biases. Despite these challenges, three major approaches are currently well-established: quantitative reverse transcription PCR (qRT-PCR), hybridizationbased methods (for example, DNA microarrays) and high-throughput sequencing (that is, RNA-seq) (FIG. 3) . 120 and cell sorting can be used to purify specific cell types. Methods for purifying miRNA populations of interest include size purification by gel electrophoresis and AGO2 immunoprecipitation (AGO2-IP) with or without ultraviolet crosslinking and immunoprecipitation (CLIP). miRNA isolation methods are similar to total RNA isolation, and widely commercially available extraction kits typically use a chemical extraction combined with a purification step that involves binding and eluting from a silica column. Formalin-fixed or formalin-fixed paraffin-embedded tissue or tumour requires additional deparaffinization and protease treatment. Various methods can be used to assess miRNA quality after extraction. For most samples, these methods include spectrophotometry, automated capillary electrophoresis with Bioanalyzer or Experion and/or determining expression of endogenous control miRNAs. For serum and plasma, which usually have total RNA yields that are too low to quantify accurately, determining the recovery of spiked-in synthetic miRNA oligonucleotides can be useful. qRT-PCR, quantitative reverse transcription PCR; RNA-seq, RNA sequencing.
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Laser capture microdissection
(LCM). A method for capturing specific cells of interest from heterogeneous tissue samples. Cells for capture are chosen by the operator using a microscope and are cut out from the tissue using a laser. The isolated cells can be used for various analyses, including miRNA profiling.
We discuss these in detail below and provide a decision tree in FIG. 4 to aid in determining which approach is best-suited for a given application. Several recent studies have addressed the strengths and limitations of these three principal platforms for miRNA profiling [46] [47] [48] [49] [50] . In addition to the established miRNA-profiling approaches that are commercially available, there are further emerging methods. These include: splinted ligation 51, 52 , rolling circle amplification [53] [54] [55] [56] , integrated fluidic circuits and detection methods 57-64 using nanoparticles, antibodies or molecular beacons. Such approaches are summarized in Supplementary information S3 (table) .
Quantitative reverse transcription PCR-based methods.
One major approach relies on reverse transcription of miRNA to cDNA, followed by qPCR with real-time monitoring of reaction product accumulation (known as 'realtime PCR'). An appealing aspect of this approach is the ease of incorporation into the workflow for laboratories that are familiar with real-time PCR. In order to scale this approach for miRNA profiling, reactions are carried out in a highly parallel, high-throughput form (that is, hundreds of qRT-PCR reactions measuring different miRNAs using the same reaction conditions). Commercially available customizable plates and microfluidic cards can be designed either to examine a small set of miRNAs (for example, those that regulate a pathway of interest) or to provide more comprehensive coverage (TABLE 2) . For large-scale miRNA profiling (that is, for hundreds of miRNAs) using qRT-PCR, several medium-throughput platforms are available that use pre-plated PCR primers that are typically distributed across multi-well dishes or alternatively across microfluidic cards containing nanolitre-scale wells (FIG. 3a) . Two common strategies used for priming the reverse transcription reaction to generate cDNA are enzymatic addition of a poly(A) tail and generation of a reverse transcription primer binding site using a stem-loop primer (FIG. 3a) .
A hurdle in performing highly parallel qRT-PCR is that optimal reaction conditions may vary substantially between miRNAs owing to sequence-specific differences in primer annealing. Although different vendors have sought to solve this problem using various approaches, one effective strategy has been the incorporation of locked nucleic acids (LNAs) into primers to standardize optimal miRNA primer hybridization conditions for the hundreds of PCR assays that are to be run simultaneously.
Hybridization-based methods. Microarrays were among the first methods to be used for parallel analysis of large numbers of miRNAs (FIG. 3b) , and several variations of the approach have been developed, including different approaches for fluorescent labelling of the miRNA in a biological sample for subsequent hybridization to DNAbased probes on the array (or, alternatively, on beads 6 ). One commonly used labelling approach is the enzymatically catalysed ligation of a fluorophore-conjugated nucleotide or short oligonucleotide to the terminal 3′-OH of the miRNA using T4 RNA ligase. One point to note about this approach is that miRNAs have a 5′ phosphate owing to cleavage by the RNase III class endonuclease Dicer and, in the presence of T4 RNA ligase, are at risk of circularization owing to an intramolecular ligation reaction. Therefore, labelling procedures using T4 RNA ligase generally involve an initial dephosphorylation step to remove the 5′ phosphate from the miRNAs in the biological samples. Another enzymatic-labelling approach involves 3′ tailing of the miRNA (for example, with poly(A)), following which a fluorophore-conjugated oligonucleotide may be ligated using a splinted ligation (for example, Invitrogen NCode) 49 . This tends to avoid the problem of circularization but may add a large and variable number of nucleotides during tailing, which could potentially affect hybridization properties in some cases. 
Splinted ligation
A method of labelling in which ligation of an oligonucleotide to the 3′ end of a microRNA is facilitated by a 'bridge' oligonucleotide that hybridizes to both the 3′ end of the miRNA and the 5′ end of the oligonucleotide to be ligated.
One of the limitations of enzymatic miRNA-labelling approaches is that they can be prone to substrate sequence bias 65 . Alternative chemical approaches to miRNA labelling exist, including chemical alkylationbased labelling along the miRNA (for example, Mirus Bio Label IT) and approaches based on platinum coordination chemistry with nucleic acids (for example, Kreatech ULS); these have been proposed to suffer less from sequence-specific labelling biases. It should also be kept in mind that other cellular RNAs, in addition to miRNAs, may be labelled by both enzymatic and chemical approaches, which can contribute to background signal as well as to cross-hybridization with specific miRNA probes. In cases in which this is problematic, initial size fractionation of small RNA using column-or gel-purification-based methods can be used.
As with PCR, variable T m is a problem, so LNAs can be incorporated into capture probes on the arrays 66 . Commercially available microarrays, as well as 'homebrewed' versions, differ in miRBase content, species coverage and incorporation of LNA-modified capture probes and results are not always concordant across array platforms 46 Amplicons are generated using an miRNA-specific forward primer and a reverse primer. As the DNA polymerase proceeds along the template, the TaqMan probe is hydrolysed and fluorescent dye is freed from the quencher, resulting in light emission (top middle).
In SYBR-green-based qRT-PCR, miRNA is typically polyadenylated at the 3′ end, and oligo-d(T) is used as a reverse transcription primer (bottom left). An miRNA-specific forward primer and a reverse primer that anneals to the 3′ portion of the miRNA sequence as well as to the poly(A) tail enable PCR amplification with dsDNA-intercalating SYBR green dye as the detector (bottom middle). Both TaqMan and SYBR-green-based qRT-PCR are available in 'array' format (right). b | miRNA microarray. DNA-based capture probes (which may or may not incorporate LNA-modified bases) are used to capture fluorescently tagged miRNAs; this is followed by scanning of slides and quantification of fluorescence. c | Nanostring nCounter. A bridge oligonucleotide templates ligation of an miRNA to a specific tag. Capture and detection is done by two target-specific probes: a 3′ capture probe containing biotin to allow adsorbance to the solid phase via streptavidin and a second 5′ reporter probe with an individual colour-coded sequence. No amplification or labelling of miRNA is required with this method. 
◀
Microfluidic cards
Typically, disposable cards in which fluid pressure is used to move input samples and reagents through microfabricated channels into specific locations (akin to 'wells') with high precision, permitting highly parallel and low-sample-volume, real-time PCR. miRNA microarrays have the advantage of generally being less expensive than the other profiling methods discussed and yet they allow large numbers of parallel measurements. Limitations include a restricted linear range of quantification, imperfect specificity in some cases for miRNAs that are closely related in sequence and lack of ability to perform absolute quantification of miRNA abundance easily. Therefore, they are best used for comparing relative abundance of specific miRNAs between two states (for example, 'experimental' versus 'control' or 'diseased' versus 'healthy').
Locked nucleic acids (LNAs
A recent innovation in miRNA profiling based on hybridization is the Nanostring nCounter, in which a multiplexed probe library is created using two sequencespecific capture probes that are tailored to each miRNA of interest 21, 69 (FIG. 3c ). An important advantage of this method is the ability to discriminate between similar variants with high accuracy. For example, the technology has been used to discriminate 3′ end nucleotide variants of mature miRNAs quantitatively 21 . Current limitations include limited dissemination of the instrument and the need for increased open-source software tools for data analysis.
RNA-seq.
The advent of next-generation sequencing platforms has enabled a third major approach for miRNA expression profiling, RNA-seq. The general approach begins with the preparation of a small RNA cDNA library from the RNA sample of interest, followed by the 'massively parallel' sequencing of millions of individual cDNA molecules from the library (FIG. 3d) . Bioinformatic analysis of the sequence reads identifies both known and novel miRNAs in the data sets and provides relative quantification using a digital approach (that is, the number of sequence reads for a given miRNA relative to the total reads in the sample is an estimate of relative abundance of the miRNA). The principal next-generation technologies have been well-described in the literature 70 . A summary of the important distinguishing features of these platforms with respect to miRNA profiling is in TABLE 2.
The major advantages of next-generation sequencing for miRNA profiling are detection of both novel and known miRNAs and precise identification of miRNA sequences (for example, RNA-seq can readily distinguish between miRNAs that differ by a single nucleotide, as well as isomiRs of varying length). However, it should be noted that RNA-seq-based miRNA-profiling studies typically identify a plethora of small RNAs of novel sequence (that is, putative miRNAs), but not all of these may be bona fide miRNAs 43 . Criteria have been established for the annotation of small RNA sequences as miRNAs, and these include: a sequence length of approximately 22 nt, a genomic origin that predicts a precursor RNA sequence that can fold into a duplex structure, identification in the data of reads that correspond to both -3p and -5p arms of the putative pre-miRNA hairpin and (ideally) conservation across species 71, 72 . Potential limitations of next-generation sequencing include the high cost, although this is dropping with the introduction of newer versions of the instruments (TABLE 2) , and the use of DNA 'barcoding' , which permits multiplexing of many samples in a single run. Additional limitations include the computational infrastructure required for data analysis and interpretation, as well as sequence-specific biases related to enzymatic steps in small RNA cDNA library preparation methods that favour capture of some miRNAs over others [73] [74] [75] . Single-molecule real-time (SMRT) sequencing or singlemolecule sequencing (SMS) methods promise faster and less biased output than methods that are currently in use (TABLE 2) , although they are currently hampered by higher error rates and higher cost and are not yet widely available. Although one such platform has been used to study short RNA species, to our knowledge, miRNA profiling has yet to be reported on single-molecule sequencing platforms 76 .
Pri-and pre-miRNA quantification. Much of the focus of commercial and non-commercial miRNA-profiling platforms has been on mature miRNAs. However, pri-miRNAs and pre-miRNAs are biogenesis intermediates that can be relevant for studying variations in miRNA processing, such as those reported in diseases including cancer. Northern blotting is a gold-standard approach that can detect all sizes ranging from the long pri-miRNA to the mature form, but it is limited by low throughput and low sensitivity. For measuring the primary transcript, PCR-based approaches are straightforward, and hundreds of assays are commercially available or can be designed based on publicly available data 77, 78 . Their main limitation is the extent to which a wellannotated primary sequence is available for the species of interest. For measurement of pre-miRNAs, qRT-PCR is a high-sensitivity approach, and SYBR green assays for over 200 pre-miRNAs have been reported 79 , methods for developing assays have been published 80 and automation of non-commercial assays for profiling has been demonstrated 81 . TaqMan-based pre-miRNA assays are also commercially available, and some DNA microarray Nature Reviews | Genetics A 'decision tree' is provided to assist in choosing an appropriate profiling platform for the desired application and available resources. *The cost of RNA sequencing (RNA-seq) is rapidly dropping with newer platforms and sample multiplexing using DNA barcoding. qRT-PCR, quantitative reverse transcription PCR.
platforms include probes for miRNA precursors 67, 68 . PremiRNA profiling can also be performed by RNA-seq 42 , although quantification suffers from limitations that are universal to the major sequencing-based platforms, as discussed in detail in the next section.
Data analysis and interpretation
In this section, we discuss the general approach for analysis of miRNA-profiling data, normalization methods and tools for integration of mRNA-and miRNAprofiling data sets. For a discussion of experimental and computational approaches to miRNA target prediction and associated software tools, we point readers to recent reviews 82, 83 . The processes that constitute basic miRNAprofiling data analysis can be summarized as: data processing, data quality assessment, data normalization and calculation of differential expression.
Data processing and quality assessment. For processing of the raw data, the software being used should be carefully investigated before embarking on miRNA-profiling studies. For example, it is useful to know whether there is any pre-processing of the data by instrument software (for example, automatic ROX dye normalization used in TaqMan qRT-PCR). For microarray image capture, repeated scanning using different settings is recommended to assess the variance that can be attributed to this step. Similarly, for RNA-seq applications, testing different software for sequencing read alignment can help to validate an optimal approach (reviewed in REF. 84 ).
After the raw data have been output in a useable form, quality assessment can be performed, typically by assessing the performance of internal controls (discussed in detail in the 'Normalization' section) and analysing replicates to detect biases 85 . For example, microarrays have well-known geographic biases (that is, some areas of the array perform differently from others), and this can also be a problem for qRT-PCR plates. However, such biases can be assessed by analysing replicates of internal controls that are distributed throughout the array or PCR plate. Batch effects that are related to run-to-run variation can also be detected by running a reference standard sample across different batches. Although batch effects often cannot be eliminated, their effects can be minimized by making sure that each batch of samples includes a mix of samples from different groups that are to be compared 86 . Finally, building in 'check functions' to ensure that a data-handling error has not occurred 87 is useful (such as match functions to verify there is not an 'off-by-one' error in the data merger), as is systematic recording of all data-manipulation steps to permit traceability.
Normalization. Data normalization, which is the next step after quality assessment, is crucially important for obtaining accurate results (reviewed in REF. 88 ). The goal of normalization is to adjust the data to remove variation across samples that is not related to the biological condition being studied, thereby making it easier to identify the relevant biological differences. Various approaches have been used in the literature, and some of the discrepancies between miRNA-profiling studies may be due, in part, to application of different normalization approaches.
Perhaps the most common approach for normalization of qRT-PCR data is the use of one or a few endogenous control RNAs, usually small nucleolar RNAs or miRNAs that are found to be largely invariant in a given sample set 89 . The assumption in this case is that the percell content of the endogenous control RNAs does not vary across the samples being studied; hence, adjusting the data for variation in the endogenous control RNAs should adjust for differences in input RNA as well as differences in sample quality that may influence the efficiency of PCR. One limitation of this approach is that it crucially depends on the underlying assumption of the independence of the small RNAs that have been chosen as controls from the biological variation being studied. This requires a priori empirical identification of endogenous controls that satisfy this criterion for the sample set under study.
An alternative approach that has been used for largescale miRNA-profiling data sets (for example, for several hundred miRNAs) that have been derived from qRT-PCR or microarray platforms is to use a global measure of the miRNA expression data as the normalizer. This strategy is based on the assumption that although specific miRNAs may vary across biological samples owing to biological causes, the overall pattern of expression of miRNAs is expected to be invariable and therefore a global measure of expression can be used to correct for technical and/or sample quality differences. Several authors have discussed approaches along this line [90] [91] [92] , including quantile normalization and variations on this for microarray data. One of the most thorough investigations for qRT-PCR data was a study 93 in which the global mean expression of all miRNAs that were found to be expressed in a given sample was shown to be a more stable normalizer within sample sets being studied than a range of small nucleolar RNAs (snoRNAs) and miRNAs that had been proposed as endogenous controls in previous studies. The approach was validated using multiple data sets and extended to microarray data as well. An independent group has subsequently confirmed the performance of this method 91 , making it an appealing, straightforward method for normalization of large-scale miRNA-profiling data sets. For cases in which a small number of miRNAs are being profiled (for example, a few dozen or less), the global mean of expressed miRNAs is not an appropriate strategy. However, in such cases, a pilot large-scale profiling study on a subset of samples can be done to identify specific endogenous control miRNAs using the global mean approach; these control miRNAs can then be used as normalizers for small-scale miRNA profiling 93 .
A third approach is the use of spiked-in synthetic control miRNAs that are introduced into the RNA sample at a range of known input amounts and that are not normally present in the sample (for example, miRNAs from plants may be used as spike-ins into animal RNA samples) 40, 85 . This approach has the advantages of providing rigorous quality control, correcting for many aspects of technical variation (for example, sample-to-sample differences in miRNA-labelling efficiency for microarrays or reverse transcription for qRT-PCR-based profiling) and providing normalization over a range of signal intensities, as the spiked-in miRNAs represent a range of input amounts. However, it requires that assays for the spiked-in controls be available on the platform that is being used and does not control for some technical variation, such as that due to measurement error in initial RNA quantification or pipetting. Combining the spiked-in control approach with 'endogenous' normalizer approaches, such as the global mean expression normalization method, may offer an ideal normalization strategy, although this has yet to be rigorously tested.
For miRNA profiling by next-generation sequencing analysis, normalization methods are much less welldeveloped, and the platform suffers from the limitation that the measurement of a particular miRNA is not independent of other miRNAs 88 . That is, unlike microarray or qRT-PCR technologies, if a given miRNA is present at high abundance in an RNA-seq sample, this reduces the number of sequence reads that are available for detection and quantification of other miRNAs in the sample. Currently, a common approach is to represent the abundance of a given miRNA in a sample as the percentage of total reads (or, in some cases, total mappable reads) obtained. It is important to examine the overall frequency distribution of miRNA reads between samples; if the distributions are substantially different, differential expression results may need to be interpreted with caution. In the future, the development of a statistical framework for adjusting for differences in miRNA frequency distribution, and the use of synthetic miRNA spike-in approaches may provide improved data normalization between samples and improved quantification ability in RNA-seq experiments.
Calculating differential expression. miRNA-profiling experiments typically involve making comparisons between two or more groups, and therefore the next stage of analysis is usually the calculation of differential miRNA expression between groups. The degree of fold-difference that constitutes meaningful differential expression will depend on the experimental context, although it is always useful to assess the statistical significance and false discovery rate that is associated with the differential miRNA expression. It is important to consider the dynamic range and accuracy of quantification of the platform when performing these calculations. Generally, qRT-PCR has the widest dynamic range, highest accuracy and is the only method that can easily provide absolute miRNA quantification (for example, by generating standard curves from dilutions of synthetic miRNA oligonucleotides of known concentration). miRNA microarrays are less expensive but tend to have a lower sensitivity and dynamic range and are therefore best used as discovery tools rather than as quantitative assay platforms. For RNA-seq, it is worth noting that miRNA quantification is expressed as a value relative to the total number of sequence reads for a given sample; thus, as mentioned earlier, comparisons between samples with high variance in miRNA distribution of expression may not be reliable, and absolute quantification is not possible.
Integrative analyses of miRNAs and mRNA profiles in gene regulatory networks. A major area of interest in miRNA-profiling analysis is integration of miRNA profiles with mRNA profiles and other large-scale genomic data sets (reviewed in REF. 94 ); this has the potential to yield a better understanding of gene regulation and to improve systems-level modelling. In silico tools are increasingly becoming available for functional analysis of altered miRNA subsets and for interrogation of miRNA regulatory networks [95] [96] [97] [98] [99] 
.
Future directions
In order to understand the roles of miRNAs in gene regulation and disease better, further work on profiling pri-miRNAs and pre-miRNAs is likely to be useful, as is more extensive integration with other large-scale data sets. In addition, it is becoming increasingly appreciated that miRNAs are subcompartmentalized within cells (for example, miRNA in the nucleus versus the cytoplasm or miRNAs present in different protein complexes). Therefore, new insights may be provided by miRNA profiling of specific subcellular compartments rather than extracts from whole cells, as has been the most prevalent approach. Profiling of miRNAs that are bound to their targets (for example, by HITS-CLIP or PAR-CLIP) is likely to improve as experimental methods and sequencing technologies progress. This could pay large dividends for investigations of biological processes in which miRNAs have an important regulatory role. We should also mention that other non-coding RNAs, such as PIWI-interacting RNAs (piRNAs), as well as long intergenic non-coding RNAs (lincRNAs), are increasingly recognized as having important roles in cellular physiology, and it is likely that new classes of non-coding RNA remain to be discovered. In the future, profiling methods such as RNA-seq that have the potential to detect all classes of RNA are likely to shed light on the entirety of the transcriptome.
